A recent study reveals that inhibiting certain adhesion receptors on the surface of dendritic cells, the main antigen-presenting cells of the immune system, enhances antitumor responses.
Click here for original story, New avenues for the optimzation of dendritic cell-based cancer immunotherapies
Source: ScienceDaily